STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN
UNII 9W2T4OSF98

Substance Identification & Data

This profile provides standardized clinical and technical data for Streptococcus Pneumoniae Type 19a Capsular Polysaccharide Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9W2T4OSF98.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9W2T4OSF98

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE ANTIGEN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

9W2T4OSF98

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C77777

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

ITIS TSN

966484

Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.

NCBI Taxonomy

1313

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Streptococcus Pneumoniae Type 19a Capsular Polysaccharide Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.